What is the dose and duration of cefixime (third-generation cephalosporin) for the treatment of typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime Dosing for Typhoid Fever

Cefixime is NOT recommended as first-line therapy for typhoid fever; azithromycin 20 mg/kg/day (maximum 1g/day) for 7 days is the preferred treatment, particularly in South Asia where fluoroquinolone resistance exceeds 70%. 1, 2

Why Cefixime Should Be Avoided as First-Line

  • Cefixime has documented treatment failure rates of 4-37.6% in clinical practice, making it a poor choice for empiric therapy 1
  • The World Health Organization lists cefixime only as an "alternative" option, not first-line, and recommends azithromycin as preferred treatment 1
  • If cefixime must be used, a mandatory test-of-cure at 1 week is required due to high failure rates 1
  • Cefixime performs worse than fluoroquinolones in head-to-head trials, and fluoroquinolones themselves have lower efficacy than azithromycin (OR 0.48 for clinical failure with azithromycin vs fluoroquinolones) 1

Cefixime Dosing (When Used as Alternative)

If cefixime is selected despite its limitations:

Adults and Children

  • Dose: 8 mg/kg/day as a single daily dose (or divided into two doses of 20 mg/kg/day total, maximum 400mg twice daily) 2, 3
  • Duration: 7-14 days 2, 3
  • The 14-day duration was used in older studies, but 7 days may be adequate for uncomplicated cases 2, 3

Pediatric-Specific Dosing

  • 10 mg/kg/day divided every 12 hours for 14 days was used in a randomized trial comparing cefixime to ceftriaxone 3
  • Mean time to defervescence was 8.0 ± 4.1 days in the cefixime group 3

Superior First-Line Alternative: Azithromycin

Instead of cefixime, use azithromycin:

  • Adults: 500 mg once daily for 7 days 1, 4
  • Children: 20 mg/kg/day (maximum 1g/day) for 7 days 1, 2, 4
  • Azithromycin demonstrates dramatically lower relapse rates (OR 0.09) compared to ceftriaxone, while cefixime has documented relapse rates of 4-37.6% 1
  • Clinical cure rate with azithromycin is 85% compared to 71% with cefixime 5
  • Mean fever clearance time with azithromycin (5.8 days) is significantly shorter than cefixime (7.1 days) 5

When to Use Parenteral Ceftriaxone Instead

For severe cases requiring hospitalization:

  • Ceftriaxone 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 1, 2
  • Transition to oral therapy (azithromycin preferred) once clinically improved and afebrile for 24 hours 2
  • Ceftriaxone remains highly effective with comparable defervescence times to oral agents 3, 6

Critical Pitfalls to Avoid

  • Never use ciprofloxacin empirically for cases from South Asia due to resistance rates approaching 96% 1, 2
  • Do not rely on cefixime as first-line therapy given its 4-37.6% failure rate 1
  • Always obtain blood cultures before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 1, 2
  • Complete the full antibiotic course even if fever resolves early to prevent relapse, which occurs in 10-15% of inadequately treated cases 1
  • If using cefixime, mandatory follow-up culture at 1 week is required to confirm treatment success 1

Monitoring Expected Response

  • Expect fever clearance within 4-5 days with azithromycin, but 7-8 days with cefixime 1, 5
  • If no clinical response by day 5, consider antimicrobial resistance or alternative diagnosis 1
  • Monitor for complications (gastrointestinal bleeding, intestinal perforation) which occur in 10-15% of patients, especially with illness duration exceeding 2 weeks 1, 2

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Guidelines for Typhoid Fever in India

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Azithromycin Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.